Next generation malaria vaccine trial passes first hurdle with strong results

Next generation malaria vaccine trial passes first hurdle with strong results

A ‘next generation’ vaccine for malaria has shown success in its first human trial. The phase 1 study saw a strong immune response in 10 healthy volunteers. The vaccine was created by genetically engineering the malaria parasite to make it weaker. Scientist removed the three genes needed for it to successfully infect and cause disease in humans. None of the participants developed malaria symptoms, and showed a strong protective antibody response. 14 days ago
What is Fat Cat Wednesday?

What is Fat Cat Wednesday?

Fat Cat Wednesday is a day where FTSE 100 bosses will have already earned more than the average worker in the UK makes all year. 14 days ago
MOST POPULAR